X
19
Horizon Therapeutics, based in Ireland, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is SODIUM PHENYLBUTYRATE, with a corresponding application number 20573.
Regulatory Information RX
With a dosage strength 3GM/TEASPOONFUL
Dosage Form Route POWDER; ORAL
Reference Listed Drug Yes
Approved since 1996-04-30
Therapeutic Equivalence (TE) Code AB